ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

COGT Cogent Biosciences Inc

6.60
0.10 (1.54%)
01 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Cogent Biosciences Inc COGT NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.10 1.54% 6.60 16:35:17
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
6.50 6.46 7.257 6.93 6.50
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
09/4/202408:00GLOBECogent Biosciences Presents Data Highlighting Potential..
26/2/202415:34EDGAR2Form S-8 - Securities to be offered to employees in employee..
26/2/202408:13EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
26/2/202407:30EDGAR2Form 8-K - Current report
26/2/202407:00GLOBECogent Biosciences Reports Recent Business Highlights and..
22/2/202413:30GLOBECogent Biosciences Announces Positive Part 1b Data from..
16/2/202417:55EDGAR2Form SC 13D/A - General statement of acquisition of..
16/2/202417:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202415:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202411:51EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202407:35EDGAR2Form 8-K - Current report
14/2/202406:00GLOBECogent Biosciences Announces Oversubscribed $225 Million..
09/2/202415:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05/2/202408:00GLOBECogent Biosciences to Present SUMMIT Part 1b Data with..
25/1/202415:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202415:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202415:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202415:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202407:00GLOBECogent Biosciences Announces Planned 2024 Milestones for..
04/1/202415:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202407:00GLOBECogent Biosciences Announces Presentation at the 42nd Annual..
11/12/202307:04EDGAR2Form 8-K - Current report
11/12/202306:55GLOBECogent Biosciences Announces Positive Data from Ongoing..
09/12/202312:30GLOBECogent Biosciences Announces Positive Initial Data from..
07/12/202308:00GLOBECogent Biosciences Presents New Preclinical Data..
04/12/202307:00GLOBECogent Biosciences to Host Investor Webcast on December 11,..
29/11/202307:00GLOBECogent Biosciences Announces Poster Presentations at..
07/11/202306:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202308:18EDGAR2Form 8-K - Current report
02/11/202308:00GLOBECogent Biosciences Reports Recent Business Highlights and..
14/10/202311:30GLOBECogent Biosciences Presents Preclinical Data Highlighting..
03/10/202315:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202315:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/8/202307:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202307:14EDGAR2Form 8-K - Current report
08/8/202307:00GLOBECogent Biosciences Reports Recent Business Highlights and..
05/7/202315:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/6/202315:01GLOBECogent Biosciences Announces Closing of Upsized Public..
07/6/202308:00GLOBECogent Biosciences Announces Participation in the Jefferies..
06/6/202319:25GLOBECogent Biosciences Announces Pricing of Upsized Public..
06/6/202315:05GLOBECogent Biosciences Announces Proposed Public Offering of..
03/6/202313:15GLOBECogent Biosciences Announces Positive Lead-In Data from..
23/5/202307:00GLOBECogent Biosciences to Host Investor Webcast to Discuss..
09/5/202307:00GLOBECogent Biosciences Reports Recent Business Highlights and..

Su Consulta Reciente

Delayed Upgrade Clock